Cambrian Bioworks develops nucleic acid extraction technologies and tools for molecular diagnostics and life science research, enhancing workflow efficiency in applications such as sequencing and genotyping. Their products, including the Manta system, address the complexities of sample preparation and handling, making genomics more accessible and affordable.
Funding
$1.4M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Nucleic acid extraction and sample preparation are complex, time-consuming steps in molecular diagnostics and life science research workflows. Traditional methods often require manual handling, lack automation, and can be expensive, limiting accessibility and efficiency.
Solution
Cambrian Bioworks develops technologies and tools to streamline nucleic acid extraction and simplify molecular workflows. Their products, including the Manta system, address the challenges of sample preparation by automating processes and reducing manual handling. By focusing on workflow efficiency, Cambrian Bioworks aims to make genomics more accessible and affordable for researchers and diagnostic companies. The company provides a range of products, including plastics, reagents, nanomaterials, and tools that serve as building blocks for diagnostics and life science research.
Target Audience
The primary customers are molecular diagnostics companies and life science researchers in fields such as sequencing, genotyping, and molecular biology.
Features
- Manta system for automated nucleic acid extraction
- Consumables such as PCR plate sealing film
- Products applicable to molecular diagnostics, sequencing, genotyping, protein chemistry, molecular and cell biology workflows, automation, and devices
- Products applicable to liquid biopsy and mRNA handling